Wall Street Analysts Think Corbus Pharmaceuticals (CRBP) Could Surge 43.82%: Read This Before Placing a Bet

Corbus Pharmaceuticals (CRBP) closed the last trading session at $59.70, gaining 2.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 85.86 indicates a 43.8% upside potential. The average comprises seven short-term price targets ranging from a low of $76 to a high of$ 105, with a standard deviation of $9.30. While the lowest estimate indicates an increase of 27.3% from the current ...